Taro Pharmaceutical Industries Statistics Share Statistics Taro Pharmaceutical Industries has 37.58M
shares outstanding. The number of shares has increased by 0%
in one year.
Shares Outstanding 37.58M Shares Change (YoY) 0% Shares Change (QoQ) 0% Owned by Institutions (%) 12.42% Shares Floating 8.09M Failed to Deliver (FTD) Shares 14,573 FTD / Avg. Volume 44.26%
Short Selling Information The latest short interest is 96.93K, so 0% of the outstanding
shares have been sold short.
Short Interest 96.93K Short % of Shares Out n/a Short % of Float n/a Short Ratio (days to cover) 3.68
Valuation Ratios The PE ratio is 29.47 and the forward
PE ratio is null.
Taro Pharmaceutical Industries's PEG ratio is
0.27.
PE Ratio 29.47 Forward PE n/a PS Ratio 2.52 Forward PS n/a PB Ratio 0.89 P/FCF Ratio 20.3 PEG Ratio 0.27
Financial Ratio History Enterprise Valuation Taro Pharmaceutical Industries has an Enterprise Value (EV) of 1.22B.
EV / Sales 1.95 EV / EBITDA 31.88 EV / EBIT 9.25 EV / FCF 15.66
Financial Position The company has a current ratio of 3.61,
with a Debt / Equity ratio of 0.
Current Ratio 3.61 Quick Ratio 3.04 Debt / Equity 0 Debt / EBITDA n/a Debt / FCF n/a Interest Coverage 0
Financial Efficiency Return on Equity is 3% and Return on Invested Capital is 0.78%.
Return on Equity 3% Return on Assets 2.49% Return on Invested Capital 0.78% Revenue Per Employee $404.88K Profits Per Employee $34.66K Employee Count 1,554 Asset Turnover 0.29 Inventory Turnover 1.58
Taxes Income Tax 28.8M Effective Tax Rate 34.84%
Stock Price Statistics The stock price has increased by 0.02% in the
last 52 weeks. The beta is 0.56, so Taro Pharmaceutical Industries's
price volatility has been higher than the market average.
Beta 0.56 52-Week Price Change 0.02% 50-Day Moving Average 42.5 200-Day Moving Average 40.2 Relative Strength Index (RSI) 64.79 Average Volume (20 Days) 32,927
Income Statement In the last 12 months, Taro Pharmaceutical Industries had revenue of 629.18M
and earned 53.87M
in profits. Earnings per share was 1.43.
Revenue 629.18M Gross Profit 304.98M Operating Income 21.51M Net Income 53.87M EBITDA 38.4M EBIT 7.31M Earnings Per Share (EPS) 1.43
Full Income Statement Balance Sheet The company has 362.91M in cash and 0 in
debt, giving a net cash position of 362.91M.
Cash & Cash Equivalents 362.91M Total Debt n/a Net Cash n/a Retained Earnings n/a Total Assets 2.16B Working Capital 942.3M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was 132.39M
and capital expenditures -54.22M, giving a free cash flow of 78.17M.
Operating Cash Flow 132.39M Capital Expenditures -54.22M Free Cash Flow 78.17M FCF Per Share 2.08
Full Cash Flow Statement Margins Gross margin is 48.47%, with operating and profit margins of 3.42% and 8.56%.
Gross Margin 48.47% Operating Margin 3.42% Pretax Margin 13.14% Profit Margin 8.56% EBITDA Margin 6.1% EBIT Margin 3.42% FCF Margin 12.42%
Dividends & Yields TARO does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield 3.39% FCF Yield 4.92%
Dividend Details Analyst Forecast Currently there are no analyst rating for TARO.
Price Target n/a Price Target Difference n/a Analyst Consensus n/a Analyst Count n/a
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value $7.15 Lynch Upside -83.36% Graham Number 39.22 Graham Upside -8.75%
Stock Splits The last stock split was on Jul 27, 2001. It was a
forward
split with a ratio of 2:1.
Last Split Date Jul 27, 2001 Split Type forward Split Ratio 2:1
Scores Altman Z-Score 3.49 Piotroski F-Score 7
